Literature DB >> 16374702

Amplatzer angled duct occluder for closure of patent ductus arteriosus larger than the aorta in an infant.

I B Vijayalakshmi1, N Chitra, R Rajasri, A N Prabhudeva.   

Abstract

Transcatheter closure of patent ductus arteriosus (PDA) by Amplatzer duct occluder is the treatment of choice. However, closure of very large ducts in infants with low weight is a challenge for the interventionalist because a large device may obstruct the aorta or left pulmonary artery. Difficulty is also encountered in advancing the device around the curve of the right ventricular outflow tract toward the pulmonary artery; this curve is tight, more or less at a right angle in infants, leading to kinking of the sheath, which increases fluoroscopic time. This is the first reported case of a very large PDA (8.7 mm), larger than the aorta (8.2 mm), successfully closed by an Amplatzer angled duct occluder in an infant weighing 5 kg.

Entities:  

Mesh:

Year:  2005        PMID: 16374702     DOI: 10.1007/s00246-004-0794-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  2 in total

1.  First closure of a large patent ductus arteriosus in an infant with an angulated nitinol plug.

Authors:  Peter Ewert; Oliver Kretschmar; Jan H Nuernberg; Nicole Nagdyman; Peter E Lange
Journal:  Catheter Cardiovasc Interv       Date:  2002-09       Impact factor: 2.692

2.  Transcatheter occlusion of patent ductus arteriosus using a new angled Amplatzer duct occluder: initial clinical experience.

Authors:  Jozef Masura; Pavol Gavora; Tomaz Podnar
Journal:  Catheter Cardiovasc Interv       Date:  2003-02       Impact factor: 2.692

  2 in total
  2 in total

1.  Transcatheter closure of patent ductus arteriosus: Evaluating the effect of the learning curve on the outcome.

Authors:  Ahmad S Azhar; Ayman A Abd El-Azim; Hamed S Habib
Journal:  Ann Pediatr Cardiol       Date:  2009-01

2.  Complications after transcatheter closure of patent ductus arteriosus.

Authors:  Gi Young Jang; Chang Sung Son; Joo Won Lee; Jae Young Lee; Soo Jin Kim
Journal:  J Korean Med Sci       Date:  2007-06       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.